ArticleEuropean journal of pediatrics2026
Tailoring discharge planning after pediatric febrile urinary tract infection: a cohort study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Febrile urinary tract infections (fUTIs) are a common cause of hospitalization in children and may recur in predisposed patients. Although current recommendations define indications for imaging and specialist referral, limited guidance is available to help hospital pediatricians identify, during hospitalization, children with clinical features associated with recurrent fUTI and tailor discharge planning accordingly. We conducted a retrospective, nationwide Italian cohort study including children aged 2 months to 3 years who were hospitalized for fUTI. Routinely collected clinical, laboratory, microbiological and imaging data were analyzed. Patients were stratified by sex and by the presence or absence of previously diagnosed congenital anomalies of the kidney and urinary tract (CAKUT). Adjusted multivariable logistic regression analyses were performed to identify factors associated with recurrent fUTIs. A total of 570 children were included, with a median age of 0.55 years. In the overall cohort, recurrent fUTIs were independently associated with older age, previously diagnosed CAKUT, acute kidney injury (AKI), and hydronephrosis with anterior-posterior diameter of the pelvis 5-15 mm. Among males with previously diagnosed CAKUT, recurrent fUTIs were independently associated with phimosis. Among males without previously diagnosed CAKUT, they were independently associated with AKI and non-E. coli infection. Among females, AKI was independently associated with recurrent fUTIs regardless of CAKUT status.
conclusionsIn children hospitalized for fUTIs, readily available clinical, laboratory, microbiological, and imaging findings are associated with recurrent fUTIs. Considering these elements during hospitalization may help hospital pediatricians identify children who may benefit from targeted interventions and tailored discharge planning. WHAT IS KNOWN: • Current Italian recommendations provide guidance on imaging and specialist referral after pediatric febrile urinary tract infection (fUTI) but offer limited guidance for discharge planning. • Several clinical factors are associated with recurrent fUTI. WHAT IS NEW: • In boys, recurrent fUTIs were independently associated with phimosis in those with known CAKUT and with AKI and non-E. coli infection in those without known CAKUT, whereas in girls AKI was the only independent factor regardless of CAKUT status. • These findings were translated into a practical framework to support tailored discharge planning for hospital pediatricians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.